The fully linked HTML version of this article has now been published.
Development ePress online publication date 16 Aug 2006
doi: 10.1242/dev.02519
Research article
Development of heart valves requires Gata4 expression in endothelial-derived cells
José Rivera-Feliciano,
Kyu-Ho Lee,
Sek Won Kong,
Satish Rajagopal,
Qing Ma,
Zhangli Springer,
Seigo Izumo,
Clifford J. Tabin,
and
William T. Pu*
* Author for correspondence (e-mail: wpu{at}enders.tch.harvard.edu)
Cardiac malformations due to aberrant development of the atrioventricular (AV) valves are among the most common forms of congenital heart disease. At localized swellings of extracellular matrix known as the endocardial cushions, the endothelial lining of the heart undergoes an epithelial to mesenchymal transition (EMT) to form the mesenchymal progenitors of the AV valves. Further growth and differentiation of these mesenchymal precursors results in the formation of portions of the atrial and ventricular septae, and the generation of thin, pliable valves. Gata4, which encodes a zinc finger transcription factor, is expressed in the endothelium and mesenchyme of the AV valves. Using a Tie2-Cre transgene, we selectively inactivated Gata4 within endothelial-derived cells. Mutant endothelium failed to undergo EMT, resulting in hypocellular cushions. Mutant cushions had decreased levels of Erbb3, an EGF-family receptor essential for EMT in the atrioventricular cushions. In Gata4 mutant embryos, Erbb3 downregulation was associated with impaired activation of Erk, which is also required for EMT. Expression of a Gata4 mutant protein defective in interaction with Friend of Gata (FOG) cofactors rescued the EMT defect, but resulted in a decreased proliferation of mesenchyme and hypoplastic cushions that failed to septate the ventricular inlet. We demonstrate two novel functions of Gata4 in development of the AV valves. First, Gata4 functions as an upstream regulator of an Erbb3-Erk pathway necessary for EMT, and second, Gata4 acts to promote cushion mesenchyme growth and remodeling.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. J. Barrick, R. B. Roberts, M. Rojas, N. M. Rajamannan, C. B. Suitt, K. D. O'Brien, S. S. Smyth, and D. W. Threadgill
Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice
Am J Physiol Heart Circ Physiol,
July 1, 2009;
297(1):
H65 - H75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Araki, G. Chan, S. Newbigging, L. Morikawa, R. T. Bronson, and B. G. Neel
Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation
PNAS,
March 24, 2009;
106(12):
4736 - 4741.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rojas, S. W. Kong, P. Agarwal, B. Gilliss, W. T. Pu, and B. L. Black
GATA4 Is a Direct Transcriptional Activator of Cyclin D2 and Cdk4 and Is Required for Cardiomyocyte Proliferation in Anterior Heart Field-Derived Myocardium
Mol. Cell. Biol.,
September 1, 2008;
28(17):
5420 - 5431.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kaneko, X. Li, X. Zhang, J. J. Lamberti, S. W. Jamieson, and P. A. Thistlethwaite
Endothelial Expression of Bone Morphogenetic Protein Receptor Type 1a is Required for Atrioventricular Valve Formation
Ann. Thorac. Surg.,
June 1, 2008;
85(6):
2090 - 2098.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Wagner and M. A. Q. Siddiqui
Signal Transduction in Early Heart Development (II): Ventricular Chamber Specification, Trabeculation, and Heart Valve Formation
Experimental Biology and Medicine,
July 1, 2007;
232(7):
866 - 880.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
